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STUDY PROTOCOL
The SUMMIT ambulatory-ICU primary 
care model for medically and socially complex 
patients in an urban federally qualified health 
center: study design and rationale
Brian Chan1,2* , Samuel T. Edwards1,3, Meg Devoe1,2, Richard Gil1,2, Matthew Mitchell2, Honora Englander2,4, 
Christina Nicolaidis1,5, Devan Kansagara1,3, Somnath Saha1,3 and P. Todd Korthuis1
Abstract 
Background: Medically complex urban patients experiencing homelessness comprise a disproportionate number 
of high-cost, high-need patients. There are few studies of interventions to improve care for these populations; their 
social complexity makes them difficult to study and requires clinical and research collaboration. We present a protocol 
for a trial of the streamlined unified meaningfully managed interdisciplinary team (SUMMIT) team, an ambulatory ICU 
(A-ICU) intervention to improve utilization and patient experience that uses control populations to address limitations 
of prior research.
Methods/design: Participants are patients at a Federally Qualified Health Center in Portland, Oregon that serves 
patients experiencing homelessness or who have substance use disorders. Participants meet at least one of the 
following criteria: > 1 hospitalization over past 6 months; at least one medical co-morbidity including uncontrolled 
diabetes, heart failure, chronic obstructive pulmonary disease, liver disease, soft-tissue infection; and 1 mental health 
diagnosis or substance use disorder. We exclude patients if they have < 6 months to live, have cognitive impairment 
preventing consent, or are non-English speaking. Following consent and baseline assessment, we randomize partici-
pants to immediate SUMMIT intervention or wait-list control group. Participants receiving the SUMMIT intervention 
transfer care to a clinic-based team of physician, complex care nurse, care coordinator, social worker, and pharmacist 
with reduced panel size and flexible scheduling with emphasis on motivational interviewing, patient goal setting 
and advanced care planning. Wait-listed participants continue usual care plus engagement with community health 
worker intervention for 6 months prior to joining SUMMIT. The primary outcome is hospital utilization at 6 months; 
secondary outcomes include emergency department utilization, patient activation, and patient experience measures. 
We follow participants for 12 months after intervention initiation.
Discussion: The SUMMIT A-ICU is an intensive primary care intervention for high-utilizers impacted by homelessness. 
Use of a wait-list control design balances community and staff stakeholder needs, who felt all participants should 
have access to the intervention, while addressing research needs to include control populations. Design limitations 
include prolonged follow-up period that increases risk for attrition, and conflict between practice and research; 
including partner stakeholders and embedded researchers familiar with the population in study planning can miti-
gate these barriers.
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Introduction
A small group of high cost-high needs patients (HCHN) 
accounts for a disproportionate percentage of health care 
expenditures [1, 2]. These patients often have multiple 
medical and psychiatric comorbidities and functional 
impairments [3] that lead to costly and unnecessary care 
[4], and have increased risk for adverse drug events [5]. 
The number of specialty physicians involved in their care 
also increases risk of fragmentation of care [6], and poor 
transitions of care from hospital to home [7–9]. In addi-
tion, highly prevalent adverse social factors, such as pov-
erty, homelessness, and substance use disorders increase 
the risk for overuse of hospital and emergency depart-
ments (ED), as well as underuse of primary care [10].
As healthcare systems and Accountable Care Organi-
zations (ACOs) assume more financial risk for quality 
of care delivered to patients, there are efforts to focus 
and intensify resources for HCHN patients [11]. Inno-
vative intensive primary care (IPC) programs employ 
a variety of approaches to improve care quality and 
reduce utilization, including use of multi-disciplinary 
care teams, increased primary care access, improved 
coordination and continuity of primary care, and 
enhanced self-efficacy through counseling or link-
ages to social services/case management [2, 12]. How-
ever, there is unclear evidence for IPC effectiveness. A 
recent systematic review of IPCs showed mixed effects 
on utilization [13]. The only study targeting patients 
with complex social needs examined the VA homeless 
patient aligned care team (H-PACT) program, an inten-
sive “ambulatory-ICU” (A-ICU) program for homeless 
Veterans who were unwilling or unable to access tra-
ditional primary care [14]. While 6-months pre- and 
post-enrollment analyses showed a 25% reduction 
in combined hospitalization and ED utilization, the 
evaluation lacked a control group. Other gaps in the 
literature include few interventions targeting HCHN 
patients in urban community health centers, and those 
with substance use disorders and co-occurring severe 
mental illness, independent risk factors for utilization 
of healthcare services [15–17].
There are several reasons for this gap. These patients 
are difficult to recruit in studies because of their social 
complexity, and distrust of medical system and may 
require partnered collaboration between research-
ers and community-based clinics beyond traditional 
research methods [18]. Furthermore, these programs 
occur in real-time in response to stakeholder and 
patient needs, and evaluation plans are often lower 
priority than service delivery—there are few learning 
health systems that have the resources or expertise to 
conduct evaluation activities in Federally Qualified 
Health Center (FQHC) populations [19, 20].
We designed SUMMIT (Streamlined Unified Mean-
ingfully Managed Interdisciplinary Team) to address 
some of these gaps. We describe a practiced-based 
research partnership between Old Town Clinic (OTC), 
an FQHC, and Oregon Health & Science University 
(OHSU), a research institution, in design of a rand-
omized, wait-list control trial to assess whether an 
A-ICU model of care compared to existing patient 
centered medical home (PCMH) care improves health-
care utilization, patient experience, and self-efficacy at 
6 months for medically and socially complex patients in 
an urban healthcare for the homeless setting.
Trial registration ClinicalTrials.gov NCT03224858, Registered 7/21/17 retrospectively registered https ://clini caltr ials.gov/
ct2/show/NCT03 22485 8
Keywords: Primary care innovation, Health service delivery, Patient experience, Patient centered medical home, 
Partnered-research, Complex care, Homelessness, Substance use
Fig. 1 Study timeline for SUMMIT study using “wait-list control” design. Participants are randomized to start immediately in SUMMIT or continue 
“usual care” for 6 months before joining SUMMIT
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Methods/design
Study design and rationale
SUMMIT is a randomized controlled study using a 
wait-list control design (see Fig.  1), described in prior 
practice-based research literature [21, 22]. Patients are 
randomized to start the SUMMIT intervention immedi-
ately, or continue with usual primary care for 6 months 
before crossing over to the SUMMIT intervention with 
data collection at multiple time-points. Thus, we address 
limitations of other practiced-based evaluations of IPC 
interventions that use pre-post designs without control 
groups. Furthermore, compared to a randomized con-
trolled trial, the wait-list control design is more accept-
able to clinic staff, patients, and payer stakeholders who 
may consider it unethical to deny patients access to the 
intervention. The wait-list control design permits gradual 
ramp-up of staffing.
Study setting
We recruit study participants from the OTC, an inte-
grated medical and behavioral healthcare clinic and 
FQHC in Portland, Oregon. OTC serves over 5000 
patients who receive primary care services at the clinic 
through four PCMH teams. The average age of OTC 
patients is 48.7  years (± 12.5), and a majority are male 
(60.9%), White/Non-Latino race/ethnicity (72.2%) with 
very low incomes (46.5%); about one-third (30%) have 
at least two chronic medical conditions. Many of OTC 
patients are referred from housing programs or sub-
stance-use treatment programs—67% of OTC patients 
in 2017 were homeless or unstably housed, and 61% 
of patients had a substance use disorder diagnosis. In 
addition to primary care, the clinic provides co-located 
mental health services delivered by psychiatric nurse 
practitioners; substance use counseling services and 
pharmacotherapy for alcohol and opioid use disorders; 
chronic disease pharmacists and an on-site pharmacy 
and lab services; wellness and activity classes, including 
daily acupuncture; integrated occupational and physi-
cal therapy, and social work services. Additionally, teams 
have access to community health workers to assist with 
patient engagement with primary care. Despite this 
specialized care, a subset of OTC patients continued to 
consume provider and staff attention and over utilize 
hospitals and EDs. A 2014 needs assessment showed 25% 
of OTC’s patients had at least one hospitalization or six 
ED visits in the preceding year, and an additional 14% 
had 2–5 ED visits in the preceding year, spurring devel-
opment of the SUMMIT intervention.
Starting in 2006, OHSU and OTC initiated a clinical 
partnership with the goal of working together to iden-
tify research opportunities in healthcare disparities, 
integrated care models and improved access for under-
served populations. OHSU-affiliated providers staff OTC 
clinics, supervise resident continuity clinics, and devel-
oped a social medicine curriculum for medical students. 
More recently, OHSU clinician-researchers embedded at 
OTC have leveraged the partnership with OTC to design 
clinical innovations on hospital-based transitions of care, 
and substance use treatment that utilizes the strengths of 
each organization [23, 24]. These prior studies were suc-
cessful in part due to intimate knowledge of the culture 
of the clinic, patient populations needs, and an awareness 
of the needs of the partner. Interest in a novel A-ICU 
care model prompted opportunity to utilize this research 
collaboration.
Eligibility criteria and recruitment
Box  1 summarizes participant inclusion and exclusion 
criteria. Primary care providers (PCPs) are encouraged to 
refer patients whose medical complexity, combined with 
social and behavioral factors, made it difficult for exist-
ing care teams to deliver optimal care. PCPs complete a 
referral form for patients that meet medical burden cri-
teria (at least one medical condition including conges-
tive heart failure, uncontrolled diabetes, advanced COPD 
[World Health Organization group C or D], chronic kid-
ney disease (≥ stage 3), end-stage liver disease, chronic 
or severe soft tissue infections, osteomyelitis, or failure 
to thrive), utilization criteria (≥ 1 hospitalization or ED 
visit in the prior 6 months), and substance use disorder 
Box 1 Summit A-ICU study enrollment criteria
Enrollment criteria
 1 or more medical/surgical hospitalizations in last 6 months
 1 or more of the following medical conditions:
  Chronic kidney disease stage III
  Congestive heart failure
  Chronic obstructive pulmonary disease, group C/D
  Diabetes with A1c > 8%
  End Stage Liver Disease (ESLD)
  Osteomyelitis/severe soft-tissue infection
 Or 1 or more of the following co-morbid conditions
  Mental health
  Substance use disorder
 Difficulty engaging in usual primary care (missed appointments)
Exclusion criteria
 Inability to consent (as demonstrated by “teach-back” method)
 Non-English speaking patients
 On hospice or deemed < 6 months to live at time of enrollment
 Diagnosis of terminal cancer
 Inability to participate in follow up assessment due to aphasia, severe 
hearing impairment or behavioral issues.
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defined by referring PCP or chart diagnosis, or behavio-
ral health criteria (≥ 1 psychotic disorder, mood disorder, 
post-traumatic stress disorder [PTSD]).
The SUMMIT team reviews referrals at regular inter-
vals to confirm clinical appropriateness. Following 
acceptance to the team, the research assistant (RA) 
approaches the patient to determine study eligibil-
ity, obtain consent and complete the baseline survey. 
We exclude potential participants if they are non-Eng-
lish speaking, are on hospice at time of enrollment 
(< 6 months to live), diagnosed with terminal cancer diag-
nosis, are unable to consent using “teachback” method 
[25], or are unable to follow-up by phone due to aphasia, 
and/or severe hearing impairment at time of enrollment.
Participant sample recruitment procedures and timeline
Once consent is obtained, the RA administers the base-
line survey that includes demographic, bio-psychosocial 
assessments and baseline assessment of patient-reported 
outcomes (Fig.  1). Following completion of the base-
line survey, the participant is randomized to immediate 
entrance into the SUMMIT intervention or placement 
on a 6-months waitlist. Study participants receive $5 gift 
cards for each completed survey.
If the participant is randomized to the wait-list con-
trol group, they remain in usual care for 6 months. After 
6 months, the RA contacts the participant to repeat the 
study assessments, and the participant transfers care to 
the SUMMIT team. If the participant is randomized to 
the intervention group, they are scheduled for an initial 
intake appointment with the SUMMIT team. The RA 
contacts participants at 6 and 12  months from date of 
enrollment for ascertainment of outcomes with a window 
of 6 weeks defined as 2 weeks prior and 4 weeks after the 
due date. Participants are followed for 12  months after 
SUMMIT enrollment (up to 18 months if assignment to 
wait-list control group).
We sought strategies to improve engagement with par-
ticipants and minimize loss to follow up, given the com-
plexity of the target population. We asked consented 
participants to list additional phone numbers and/or 
addresses as points of contact as part of baseline survey 
procedures. We convened a patient advisory group, and 
included in our research meetings a patient liason to 
introduce the SUMMIT study to obtain feedback from 
patient advocates regarding study recruitment and fol-
low-up procedures.
Study integrity and randomization
The study design conforms to CONSORT statement 
recommendations for randomized clinical trials of non-
pharmacologic treatment [26]. Upon completion of con-
sent and baseline survey, participants are randomized 
to either immediate start with the SUMMIT team or be 
placed on a 6-months wait-list with a 1:1 allocation per 
computer-generated randomization schedule. We used 
sequentially numbered, opaque, sealed envelopes to 
attain allocation concealment. A member of the research 
team not involved in the consent and enrollment process 
generated the allocation sequence. Following allocation 
of group assignment, the participant, clinic staff, and RA 
conducting follow up surveys will not be blinded. The 
research members conducting the statistical analysis will 
be blinded from treatment assignment. We will conduct 
an intent-to-treat analysis.
Ethics and dissemination
The study protocol was reviewed and approved by the 
OHSU IRB in 2016 (IRB 15285). The study also received a 
Certificate of Confidentiality from the National Institutes 
of Health to protect data on drug and alcohol use. The pro-
tocol is registered with clinicaltrials.gov (NCT03224858). 
None of the investigators have financial or competing 
interests in conflict with the aims of the trial.
Box 2 Summit A-ICU intervention description and team structure
Team structure
 Care coordinator—the patient’s primary point of contact, the care coordinator assists with patient follow up, acts as scribe for physician face-to-face 
visits, conducts outreach activities with the goal of enhancing rapport building
 Team manager—the team manager coordinates patient and team schedules, interfaces with clinic operations and administration, conducts outreach, 
and leads team activities, including organizing trainings, and process improvement cycles
 Physician—General internist with additional board certification in addiction who provides front line care to patients including acute and chronic 
disease management, advanced care planning, medication management, and coordination of care with specialists
 Social worker—a licensed clinical social worker embedded in the team who meets with the patients on Day 1 to elicit social vulnerabilities and pro-
vide counseling + case management support to patients as needed
 Complex care nurse—a nurse that provides medical triage services, transitional care planning, and assists patients with health education activities as 
well as outreach (accompanying patients to specialty appointments)
 Pharmacist—the pharmacist works with patients and team members to assist with medication reconciliation, transitions of care, and chronic disease 
medication management for patients (diabetes, heart disease) with the goal of reducing medication treatment burden
Page 5 of 11Chan et al. Addict Sci Clin Pract           (2018) 13:27 
The team has flexibility to conduct home visits, facilitate 
unscheduled clinic visits, accompany patients to specialty 
appointments, and deliver addictions treatment includ-
ing medications for addiction treatment. The quality ana-
lyst assists the team in developing “Plan-Do-Study-Act” 
cycles and panel management activities.
Funding SUMMIT
SUMMIT is funded through reallocation of existing staff 
resources and clinical operations budget, rather than 
grants. Funding for on-going operations is through a 
negotiated per-member per-month payment for partici-
pants in the care model and fee-for-service payments for 
patient visits with a regional Medicaid payor.
Wait‑list controls: treatment as usual
Usual care operates as a PCMH model (see Fig.  2). 
Within the clinic, there are four teams consisting of 
PCP, care team manager (usually a licensed practi-
cal nurse), medical assistants, and health assistants 
who handle clerical and phone communication duties. 
Patients have referral access to on-site non-medical 
services described above, including addictions treat-
ment, housing referrals, and behavioral health. In 2015, 
Box 3 Key features and core activities of summit A-ICU
1. Transfer of care to the co-located stand-alone team Patients transfer care from existing primary care to the SUMMIT team to encourage coordinated, 
unified care from a single team. Co-location offers opportunity to facilitate interdisciplinary meetings, as well as informal conversations to enact care 
plans during non-visit time
2. Comprehensive initial intake The first visit(s) include a 60 min social intake with the Social worker, followed by a 60 min medical intake with provider/
care coordinator with open ended questions and focus on patient health goal elicitation and assessing self-efficacy and treatment burden. The visit 
forms the basis for the patient-centered, goal-based care plan
3. Interdisciplinary team reviews Following intake, subsequent activities and appointments are determined based on patient status, medical and psy-
chosocial complexity. Set time aside for daily huddles provide opportunity to discuss the patients scheduled for the day, and recently hospitalized or 
discharged patients. Weekly “speed dating” rounds provide opportunity to review existing patients assess whether current interventions are working 
and revise care plans as necessary
4. Transitions of care coordination/tracking Led by the complex care nurse, and pharmacist, the SUMMIT team developed protocols for coordination 
of care for hospitalized patients to communicate pertinent information to inpatient care teams, and develop follow up care plans prior to patient 
discharge
5. Built-in counseling services Led by the social worker but supported by all team members who are trained in motivational interviewing, trauma-
informed care, and cognitive behavioral therapy. Social workers provide individualized counseling and leverage existing linkages to mental health 
prescribers as necessary
6. Navigation of social services Team members assist patients with long term care planning, advanced directives, linkages to community resources such 
as disability, housing benefits
7. On-demand availability and access to off-hours warm lines A separate SUMMIT team phone number is available for patients and patient caregiver 
teams to access SUMMIT team members at all hours of the day. SUMMIT physicians cover the phone during off-clinic hours to respond to patient care 
needs and concerns
Additional activities/flexibility
8. Outreach visits Team members are available to conduct outreach visits for patients on an as needed basis. Visits are used as an opportunity to assess 
patients outside the clinic, develop rapport and trust, and facilitate and support a health related activity (i.e. Accompaniment to specialist referrals, 
delivery of medications if temporarily homebound, assistance with access to social services)
9. Pharmacy education/chronic disease medication management For select patients with non-controlled chronic disease conditions (diabetes, hyperten-
sion, heart disease), the SUMMIT pharmacist is available for 1 to 1 consultation and medication review and management. The pharmacist is empow-
ered to enact the care plan and titration or tapering of medications
10. In-visit scribing Care coordinators sit in on medical visits with provider and patients and scribe for the provider. This activity promotes unified com-
munication of the care plan between patient, care coordinator, and physician; and allows improved patient experience during face-to-face visits
Study arms
Intervention: SUMMIT intervention description
The intervention is a clinic team of co-located multi-
disciplinary staff with reduced panel size and flexible 
scheduling (Box  2). Staffing consists of two half-time 
physicians (1.0 FTE) with board certification in addic-
tion medicine, one complex care nurse, two care coor-
dinators, two licensed clinical social workers (LCSW), 
pharmacist, team manager, and quality analyst. All team 
members have additional training in Motivational Inter-
viewing, patient goal setting, and palliative care princi-
ples. These didactic trainings were delivered by partner 
community organizations during weekly dedicated non-
clinical time built into the SUMMIT schedule. The aims 
of the SUMMIT team are closely aligned with Shippe 
and Montori’s theory of cumulative complexity, empha-
sizing ways to increase patient self-efficacy and decrease 
treatment burden [27]. Core activities (Box 3) include an 
initial comprehensive intake with medical and behav-
ioral team members, patient driven health goal setting, 
transitional care protocols when patients experience 
hospitalizations, medication management assessment, 
weekly panel review, and case management to address 
social determinants of health and other unmet needs. 
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OTC introduced embedded CHW workers in partner-
ship with a regional Medicaid payor [2]. The CHWs 
have training in addictions or mental health counseling 
and engage HCHN patients outside the clinic setting. 
Activities of the CHW include motivational interview-
ing, case management, advocacy, facilitation of multi-
disciplinary care planning, collaboration with primary 




The RA administers baseline and follow up surveys to 
participants using paper questionnaires and then enters 
responses into a REDCap database designed with 
branching logic, range checks, and forced functions to 
increase data quality. The RA is independent from the 
clinical teams to decrease risk of social desirability bias 
in survey response. The RA stores paper questionnaires 
in a locked file cabinet on site in case of discrepancies 
in the REDCap database. We use administrative data to 
examine care utilization outcomes. If a participant is 
lost to follow up or does not engage with the care team, 




The primary outcome is total inpatient hospitalizations 
at 6 and 12 months after study enrollment as assessed by 
PreManage, a consortium of local state and cross-state 
hospitals that sends in real-time hospital administrative 
event information (inpatient admissions and discharges, 
ED visits) to health plans and provider groups.
Secondary outcomes
The secondary outcomes are ED utilization at 6 and 
12  months after study enrollment, and patient reported 
activation at 6 and 12 months of the intervention. We 
assess patient activation using the Patient Activation 
Measure (PAM-13) [28, 29], a validated tool used widely 
in research to assist in tailoring care plans, and evalua-
tion assessment.
Exploratory outcomes
We will also consider pre-specified, exploratory out-
comes (Table  1). We will use PreManage to calculate 
average length of stay per inpatient hospitalization; 
mortality (based on chart record review); outpatient 
clinic visits; and housing status (assessed using a self-
reported survey question: “Which of the following best 
describes your current residence?”) at 6 and 12 months. 
We assess patient experience of healthcare at 6 and 
12  months using the Consumer Assessment Health-
care Professionals (CAHPS); [30] we also assess patient 
Fig. 2 Comparison of “usual care” team (left) and SUMMIT A-ICU (right)
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reported quality of life using the SF-12 survey [31], a 
single item palliative care measure (Edmonton Symp-
tom Assessment System (ESAS) [32], and a six-item life 
chaos measure by Wong that assessed self-reported rat-
ings of participants’ routines and daily activities [33]. 
We will assess the impact of SUMMIT on all OTC clini-
cal staff by assessing a two-item burnout measure peri-
odically during implementation [34].
Socio‑demographic and other potential covariates
Self-reported socio-demographic variables include age, 
gender, race/ethnicity, marital status, educational attain-
ment, and annual household income. Part of the motiva-
tion for this study is to learn more about these patients 
and determine how psychosocial factors, of which little 
are captured in health records or administrative data, 
play a role in their healthcare experiences. Therefore, we 
Table 1 Participant timeline and assessments (per SPIRIT guidelines) [50]
PHQ patient health questionnaire, AUDIT alcohol use disorder identification test, DAST drug abuse screening test, TICS telephone interview for cognitive status, ESSI 
Enriched social support instrument, ED emergency department, PAM patient activation measure, CAHPS consumer assessment of healthcare providers and systems, 





− t1 = 0 6 months 12 months 18 months 18 months
Enrollment
 Eligibility screen X
 Informed consent X
 Baseline 1 X
 Allocation X
Interventions
 Immediate X X
 Wait-list X X
Assessments
 Baseline 1 and 2
 “Please choose the number that best describes how you 
feel?” (0–10) [32]
X X X X X
 PHQ-9 [38] X
 AUDIT 10 [40] X
 Self reported alcohol use disorder history X
 DAST [40] X
 Self report substance use disorder history X
 Tobacco use X
 Self reported falls over 6 months X
 Telephone interview for cognitive status (TICS14) [51] X
 Health Literacy 3 item questionnaire [36] X
 ESSI 7 social support questionnaire [20] X
 Food security 2 [3, 7] X
 Income source X
 Education X
 Race-ethnicity X
 Housing status X X X X X
Outcomes
 ED visits 6 months prior X X X X X
 Hospitalizations 6 months prior X X X X X
 PAM-13 [29] X X X X X
 CAHPS-10 [52] X X X X X
 SF-12v2 [31] X X X X X
 Chaos Scale 6 [33] X X X X X
 Mortality/death X X X X X
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also assessed perceived social support [35], current liv-
ing situation, self-reported health literacy [36], and food 
insecurity [37]. We also screen for depression using the 
patient health questionnaire (PHQ-9) [38], cognitive 
impairment using telephone interview for cognitive sta-
tus (TICS) [39], and drug and alcohol use disorders using 
the drug abuse screening test (DAST) and the alcohol use 
disorder identification test (AUDIT) [40]. Measures were 
proposed during planning meetings, and pilot tested 
prior to finalizing.
Sample size calculations
We conducted several sample size calculations to esti-
mate the study size population.
We examined the sample size necessary to demonstrate 
a 40% reduction in our primary outcomes of hospital uti-
lization over 6 months. We determined average number 
of hospitalizations over the prior 6  months for a pilot 
sample of SUMMIT patients (2.3 hospitalizations/per-
son over 6 months, SD = 1.9). Assuming 80% power and 
2-tailed alpha, the sample size estimated was 140 partici-
pants. Based on preliminary data, we believed 400 exist-
ing patients met SUMMIT eligibility for utilization, but 
targeted an enrollment of 200 based on potential difficul-
ties with recruitment and retention. We used prior litera-
ture to determine an effect size of a four-point increase 
on the secondary outcome of PAM score, with stand-
ard deviation of 10; therefore, at 80% power and 2 tailed 
alpha, the sample size estimated was 196 [41].
Statistical analyses
We will use descriptive statistics to describe the study 
population and assess similarity of baseline character-
istics between study arms using Chi square, t-tests, and 
Fisher’s exact test. For each outcome, we will conduct 
intent-to-treat analyses using difference-in-differences 
regression to compare the study arms during baseline 
and 6-months and 12-months follow up [42]. Use of a 
wait-list control design permits two methodologies to 
assess outcome changes. The first analysis will be a com-
parison of intervention and control group outcomes at 
6-months, adjusting for any baseline covariates that dif-
fer by chance in each group. The second analysis will 
use the wait-list control to conduct a repeated measures 
analysis controlling for calendar time to account for secu-
lar changes in the intervention and enhanced usual care 
groups over time. We also plan to conduct pre-specified 
sub-group analyses to identify which SUMMIT patients 
benefit most from the intervention as currently con-
structed, including: study participants with only medical 
complexity; participants with active/primary substance 
use disorders; and participants who have housing insta-
bility at enrollment. Though these subgroup analyses will 
likely be underpowered, they may inform refined referral 
criteria or assist in a refined intervention.
Qualitative and formative evaluation
In addition to the primary evaluation, we are conduct-
ing qualitative interviews with clinical staff members 
and patient participants to explore how the intervention 
evolves over time and gain insights for what intervention 
activities worked well and what can be improved. We are 
conducting formative evaluation through quantitative 
and qualitative methods to describe intervention com-
ponents, assess fidelity, and develop lessons learned [43]. 
This includes tracking number of visits to medical, men-
tal health, pharmacy, nursing providers, tracking whether 
patients received SUMMIT core activities, and docu-
menting issues affecting implementation of the program 
as intended.
Data monitoring
The research team will produce administrative reports 
on a quarterly basis that describe study progress includ-
ing: accrual, demographic, study subjects status, out-
standing REDCap study forms, error rate pertaining to 
adherence to inclusion/exclusion criteria and the study 
protocol. These reports will be reviewed internally for 
ongoing quality control and submitted at the request of 
the IRB.
Discussion
This paper describes a partnered approach to design 
and evaluation of a novel intensive A-ICU model of pri-
mary care for medically and socially complex patients at 
an FQHC clinic primarily serving low-income patients 
experiencing homelessness or substance use disorders. 
The results of this study will contribute to an evolving 
literature on intensive primary care interventions that 
addresses two gaps: (1) a need for more practiced-based 
research studies that include control populations; and (2) 
a focus on HCHN patients with high rates of homeless-
ness and substance use.
While there is interest in improving quality of care 
and lowering costs for HCHN patients, how to achieve 
this is unclear. Intensive primary care interventions are 
an approach popularized by Camden Coalition’s “Hot-
spotters” [44] and others like it; however, there are few 
published evaluations to support investing resources 
into these models. There are several reasons why these 
studies do not get published. Many of these intervention 
programs lack resources or expertise to conduct formal 
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evaluations and dissemination activities—often, pro-
grams are implemented, and community partners move 
on to the next pressing need. Another reason is that 
multi-component interventions like those for HCHN 
patients are difficult to describe and vary depending 
on local context [13, 45]. Patients affected by poverty, 
homelessness, and substance use are understudied, and 
have stigma associated with research participation that 
makes traditional clinical trial participation challeng-
ing. Our study protocol addresses these limitations by 
using a community-partnered approach and embedded 
researchers that meets both programmatic and research 
needs.
The wait-list randomized control design of the SUM-
MIT evaluation offers a balance between research and 
practice priorities. From a research perspective, incor-
porating randomization to a control group allows the 
study to address potential bias resulting from regression 
to the mean, and minimizes confounding that is present 
in pre-post designs. From a programmatic perspective, 
the wait-list control design meets the needs of clinical 
priorities in that all participants who are accepted have 
the opportunity to receive the intervention, and allow for 
gradual scaling up of the intervention over time to meet 
staff capacity [46, 47]. If the trial is successful, this study 
design may serve as a model for future evaluations of 
multi-component, interdisciplinary, practice-based eval-
uations of interventions for HCHN populations in other 
settings.
Use of this design is not without trade-offs, includ-
ing accounting for extended follow-up time that may 
increase risk for attrition [22]. We limited the wait-
list to 6  months and ask for multiple sources of con-
tact information from participants at baseline to help 
decrease this risk; however, assessing primary and 
secondary outcomes at 6  months may be too short a 
time period to detect noticeable differences in utiliza-
tion and self-efficacy because behavior change inter-
ventions often take up-front investments and require 
extended time horizons (i.e. multiple years) to demon-
strate efficacy [48, 49]. Implementing practice-based 
research often leads to conflicts between research and 
practice, and our experience has been no exception; 
however, use of embedded researchers familiar with 
the patient population and clinic culture, and incorpo-
rating input from stakeholders was beneficial for eval-
uation planning.
In conclusion, we are testing a novel model of primary 
care using multi-disciplinary teams with reduced panel 
size and increased flexibility as an intervention to improve 
quality of care for patients with multiple chronic medi-
cal and social complexity. The outcomes of the SUMMIT 
study will provide real-world evidence about the efficacy of 
an A-ICU model of care for HCHN patients particularly 
sensitive to social determinants of health.
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